Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

2312, 2016

Luca Reggiani Bonetti et al., Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer

1312, 2016

Chiara Cremolini et al., Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: A pooled analysis of clinical studies by Gruppo Oncologico del Nord Ovest. European Journal of Cancer

812, 2016

Beth O. Van Emburgh et al., Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications

2711, 2016

Adriana Romiti et al., The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs

2511, 2016

Laura Capelli et al., No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Scientific Reports

1211, 2016

Greta Alì et al., Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma. Oncology Letters

1211, 2016

Caterina Marchiò et al., Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept. Neuro-Oncology

811, 2016

Federico Pessina et al., Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. Journal of Neuro-Oncology

811, 2016

Harriet Johansson et al., Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Research

2610, 2016

Annemarie Boleij et al., RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres. BMC Cancer

1110, 2016

Giovanna De Maglio et al., Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach. Annals of Oncology

1110, 2016

Annarita Destro et al., The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients. Annals of Oncology

Precedente 252627 Successivo

Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Pubblicazioni

Leader in Italia nella ricerca e nella commercializzazione di kit diagnostici per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Cerca per linea

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici